Feasibility of spectral pH measurement during the low‐pH virus inactivation step of continuous therapeutic antibody production

2020 ◽  
Vol 36 (4) ◽  
Author(s):  
Jeffrey D. Goby ◽  
Kenji Furuya ◽  
Eike Zimmermann ◽  
Justin A. Beller ◽  
John M. Schmitt ◽  
...  

2006 ◽  
Vol 5 (4) ◽  
pp. 16-25 ◽  
Author(s):  
Feng Li ◽  
Brian Lee ◽  
Joe Zhou ◽  
Tim Tressel ◽  
Xiaoming Yang




2021 ◽  
Author(s):  
Nadja Raab ◽  
Nikolas Zeh ◽  
Patrick Schlossbauer ◽  
Sven Mathias ◽  
Benjamin Lindner ◽  
...  


The Analyst ◽  
2018 ◽  
Vol 143 (21) ◽  
pp. 5176-5184 ◽  
Author(s):  
James Bonner ◽  
Lance E. Talbert ◽  
Nicholas Akkawi ◽  
Ryan R. Julian

Disulfide heterogeneity and other non-native crosslinks introduced during therapeutic antibody production and storage could have considerable negative effects on clinical efficacy, but tracking these modifications remains challenging.



2018 ◽  
Vol 102 (14) ◽  
pp. 6081-6093 ◽  
Author(s):  
Yafang Lu ◽  
Qin Zhou ◽  
Qianqian Han ◽  
Pengfei Wu ◽  
Lanlan Zhang ◽  
...  




2018 ◽  
Vol 38 (15) ◽  
pp. S13-S15
Author(s):  
Mark Schofield ◽  
David Johnson
Keyword(s):  
Low Ph ◽  


2021 ◽  
pp. 2100320
Author(s):  
Pratik U. Joshi ◽  
Christa L. Meingast ◽  
Xuankuo Xu ◽  
Melissa Holstein ◽  
Hasin Feroz ◽  
...  
Keyword(s):  
Low Ph ◽  


2015 ◽  
Vol 1415 ◽  
pp. 83-90 ◽  
Author(s):  
Alice R. Mazzer ◽  
Xavier Perraud ◽  
Jennifer Halley ◽  
John O’Hara ◽  
Daniel G. Bracewell


Sign in / Sign up

Export Citation Format

Share Document